Print Get Citation Citation Disclaimer: These citations have been automatically generated based on the information we have and it may not be 100% accurate. Please consult the latest official manual style if you have any questions regarding the format accuracy. AMA Citation Davis R, Chan A. Davis R, & Chan A Davis, Rhianna, and Alex Chan. Price changes in colchicine have changed practice management for gout. 2 Minute Medicine, 16 May 2023. McGraw Hill, 2023. AccessMedicine. https://accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=626692§ionid=278430609APA Citation Davis R, Chan A. Davis R, & Chan A Davis, Rhianna, and Alex Chan. (2023). Price changes in colchicine have changed practice management for gout. (2023). 2 minute medicine. McGraw Hill. https://accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=626692§ionid=278430609.MLA Citation Davis R, Chan A. Davis R, & Chan A Davis, Rhianna, and Alex Chan. "Price changes in colchicine have changed practice management for gout." 2 Minute Medicine McGraw Hill, 2023, https://accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=626692§ionid=278430609. Download citation file: RIS (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley © Copyright Annotate Clip Autosuggest Results Price changes in colchicine have changed practice management for gout by Rhianna Davis, Alex Chan Listen +Originally published by 2 Minute Medicine® (view original article). Reused on AccessMedicine with permission. +1. The price increase of Colchicine in the United States led to greater use of alternative medications for gout treatment, as well as greater ED and rheumatology visits for gout. +Evidence Rating Level: 2 (Good) +Prices of prescription drugs have an important impact on the ability of patients to adhere to recommended medical treatments. The price of colchicine, a prescription medication used to treat gout, was increased in 2010 in the United States. This retrospective cohort study assessed MarketScan data from patients with gout and employer-based insurance between 2007 and 2019. The mean price of colchicine increased from $11.25 in 2009 to $190.49 in 2011, with the mean out-of-pocket cost increasing by 4.4-fold on average. The authors found that colchicine use declined following the price increase, with a 16.7% reduction in year 1 and a 27.0% reduction over the decade (p < .001). The use of allopurinol for gout treatment increased, with a 32% increase from baseline over the decade (p <0.001). Importantly, the authors found that from 2009-2019, ED visits for gout increased by 39.8% (p < .001), and rheumatology visits for gout increased by 10.5% (p <0.001). This study suggests that the cost of medications has a profound impact on medication choice, as well as the success of disease management. A limitation of this study is the exclusion of participants without employer-based insurance for drug coverage, given that this population is likely more impacted by changes to prescription medication costs. +Click to read the study in JAMA Network Open +©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.